Professor of Radiation Oncology, Massachusetts General Hospital
Radiology
Dr. Noah C. Choi, MD
|
|
Give Review
Dr. Noah C. Choi works in the field of Radiology. He graduated from Seoul National University College of Medicine. He over the years received 5 awards: "America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer", "Boston Herald" and "Super Doctor". Doctor Noah C. Choi, MD is also a published doctor. He has 94 publication published. The most recent publication is: Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent ... Doctor Noah C. Choi, MD is registered with Medicare and accepts Medicare payments.
Publications
- Significance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for br...
- Correlation of 18F-FDG PET avid volumes on pre-radiation therapy and post-radiation therapy FDG PET scans in recurrent lung cancer. In reply to Saraiya et al.
- Correlation of (18)F-FDG Avid Volumes on Pre-Radiation Therapy and Post-Radiation Therapy FDG PET Scans in Recurrent Lung Cancer.
- Potential of (18)F-FDG PET toward personalized radiotherapy or chemoradiotherapy in lung cancer.
- Motion Interplay as a Function of Patient Parameters and Spot Size in Spot Scanning Proton Therapy for Lung Cancer.
- Proton SBRT for medically inoperable stage I NSCLC.
- A single-nucleotide polymorphism in the MTHFR (methylene tetrahydrofolate reductase) gene is associated with risk of radiation pneumonitis in lung cancer patients trea...
- DNA Repair Biomarkers Predict Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer.
- Outcomes After Combined Modality Therapy for EGFR-Mutant and Wild-Type Locally Advanced NSCLC.
- Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer.
- POINT: Operative risk of pneumonectomy--influence of preoperative induction therapy.
- Implications of respiratory motion as measured by four-dimensional computed tomography for radiation treatment planning of esophageal cancer.
- Maximum-intensity volumes for fast contouring of lung tumors including respiratory motion in 4DCT planning.
- Quantitative assessment of range fluctuations in charged particle lung irradiation.
- Quantification of mediastinal and hilar lymph node movement using four-dimensional computed tomography scan: implications for radiation treatment planning.
- Design of 4D treatment planning target volumes.
- Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer.
- The role of radiation therapy in non-small cell lung cancer.
- Four-dimensional image-based treatment planning: Target volume segmentation and dose calculation in the presence of respiratory motion.
- Internal target volume determined with expansion margins beyond composite gross tumor volume in three-dimensional conformal radiotherapy for lung cancer.
- Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 26-2004. A 56-year-old woman with cough and a lung nodule.
- Radioprotective effect of amifostine in radiation pneumonitis.
- Radiation dose escalation in limited-stage small-cell lung cancer.
- Radiation dose intensification in limited-stage small-cell lung cancer.
- Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a ...
- Dose-response relationship between probability of pathologic tumor control and glucose metabolic rate measured with FDG PET after preoperative chemoradiotherapy in loc...
- Lymphatic metastasis in the absence of functional intratumor lymphatics.
- Induction chemoradiation compared with induction radiation for lung cancer involving the superior sulcus.
- Effects of interfractional anatomical changes on water-equivalent pathlength in charged-particle radiotherapy of lung cancer.
- Adenocarcinomas of the esophagus: response to chemoradiotherapy is associated with decrease of metabolic tumor volume as measured on PET-CT. Comparison to histopatholo...
- Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors.
- Does prophylactic cranial irradiation reduce the incidence of brain metastases in extensive small-cell lung cancer?
- Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation.
- Case records of the Massachusetts General Hospital. Case 16-2007. A 61-year-old man with a mediastinal mass.
- FDG-PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology.
- Estimation of the delivered patient dose in lung IMRT treatment based on deformable registration of 4D-CT data and Monte Carlo simulations.
- Superior sulcus lung tumors: impact of local control on survival.
- Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study.
- Induction therapy for esophageal cancer with paclitaxel and hyperfractionated radiotherapy: a phase I and II study.
- Effect of postoperative radiotherapy on changes in pulmonary function in patients with stage II and IIIA lung carcinoma.
- Assessment of preoperative accelerated radiotherapy and chemotherapy in stage IIIA (N2) non-small-cell lung cancer.
- Dynamic T1-weighted magnetic resonance imaging and positron emission tomography in patients with lung cancer: correlating vascular physiology with glucose metabolism.
- Potential impact on survival of improved tumor downstaging and resection rate by preoperative twice-daily radiation and concurrent chemotherapy in stage IIIA non-small...
- Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature resu...
- Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy i...
- Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction.
- Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study.
- A pilot study of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and postoperative radiation therapy and/or chemotherapy in adenocar...
- Preoperative chemotherapy, surgical resection, and selective postoperative therapy for squamous cell carcinoma of the esophagus.
- A method of calculating a lung clinical target volume DVH for IMRT with intrafractional motion.
- Treatment and survival in diffuse malignant pleural mesothelioma; a study of 83 cases from the Massachusetts General Hospital.
- Predictive factors in radiotherapy for non-small cell lung cancer: present status.
- Toxicity of thoracic radiotherapy on pulmonary function in lung cancer.
- Importance of radiation dose in achieving improved loco-regional tumor control in limited stage small-cell lung carcinoma: an update.
- Lung tumor metastasis to breast detected by fluorine-18-fluorodeoxyglucose PET.
- Combined modality therapy in small cell lung cancer.
- Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent ...
- Preoperative chemotherapy followed by surgery with possible postoperative radiotherapy in squamous cell carcinoma of the esophagus: evaluation of the chemotherapy comp...
- Toxicity and outcomes after chemoradiation for esophageal cancer in patients age 75 or older.
- Simplified measurement of deoxyglucose utilization rate.
- Accelerated radiotherapy followed by chemotherapy for locally recurrent small-cell carcinoma of the lung. A phase II study of Cancer and Leukemia Group B.
- A phase II comparative study of gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non-small-cell lung cancer (NSCLC): primary anal...
- Gastrin-releasing peptide gene expression in small cell and large cell undifferentiated lung carcinomas.
- Basis for new strategies in postoperative radiotherapy of bronchogenic carcinoma.
- Reassessment of loco-regional failure rate in relation with radiation dose in combined modality approach of multidrug chemotherapy and radiotherapy for limited-stage s...
- A phase II trial of cyclophosphamide, etoposide, and cisplatin with combined chest and brain radiotherapy in limited small-cell lung cancer: a Cancer and Leukemia Grou...
- Induction treatment for resectable non-small-cell lung cancer.
- Controversies in the role of postoperative radiotherapy in stages II and IIIA resected non-small cell lung carcinoma.
- Accelerated radiation therapy in small cell lung cancer: rationale and limitation in its utility.
- Pretreatment minimal staging for non-small cell lung cancer: an updated consensus report.
- Radiation therapy for postoperative local-regionally recurrent lung cancer.
- Improved quality of life of patients with small-cell carcinoma of the lung by elective irradiation of the brain.
- Induction therapy for stage III NSCLC: a consensus report.
- The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?
- Cell kinetic study of thymic epithelial tumors using PCNA (PC10) and Ki-67 (MIB-1) antibodies.
- Small cell carcinoma of the lung. A progress report of 15 years' experience.
- Prospective study of pulmonary tolerance to radiotherapy or radiotherapy plus multidrug chemotherapy for loco-regional lung carcinoma.
- Radiation therapy alone or in combination with surgery in the treatment of carcinoma of the esophagus.
- Dose intensity in lung cancer treatment.
- Pre-operative and post-operative treatments in stage III NSCLC.
- Neoadjuvant therapy for marginally resectable (clinical N2), non-small cell lung cancer. American College of Radiology. ACR Appropriateness Criteria.
- Non-small cell lung cancer, nonsurgical, aggressive therapy. American College of Radiology. ACR Appropriateness Criteria.
- Thymoma. Histologic subclassification is an independent prognostic factor.
- Reassessment of the role of postoperative radiation therapy in resected lung cancer.
- Prospective prediction of postradiotherapy pulmonary function with regional pulmonary function data: promise and pitfalls.
- Improved survival of patients with unresectable non-small-cell bronchogenic carcinoma by an innovated high-dose en-bloc radiotherapeutic approach.
- Cytologically negative pericardial effusion complicating combined modality therapy for localized small-cell carcinoma of the lung.
- Implementing multiplexed genotyping of non-small-cell lung cancers into routine clinical practice.
- The risk of intradural spinal metastases in patients with brain metastases from bronchogenic carcinomas.
- Intradural spinal metastases in patients with posterior fossa brain metastases from various primary cancers.
- Various patterns of perfusion-weighted MR imaging and MR angiographic findings in hyperacute ischemic stroke.
- Triphasic perfusion computed tomography in acute middle cerebral artery stroke: a correlation with angiographic findings.
- Low dose fractionated whole body irradiation in the treatment of advanced non-Hodgkin''s lymphoma.
Schools
Seoul National University College Of Medicine
Ont Cancer Institute Prin Mrgrt Hospital
University Hospitals Of Cleveland
Victoria General Hospital
Doctors Specialties
- Radiation Oncology
- Radiology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- GHI PPO
- Fallon Community Health Plan
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tufts PPO
- UniCare
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Boston Herald
- Super Doctor
Education
-
Case Western Reserve University - University Hospitals -
Seoul National University College of Medicine
Hospital
-
Emerson Hospital -
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1467434019 | |
| NPPES Provider LastName | CHOI | |
| NPPES Provider FirstName | NOAH | |
| NPPES Provider ZIPCode | 021142606 | |
| NPPES Provider State | MA | |
| Specialty Description | Diagnostic Radiology | |
| Total Claim Count | 17.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467434019 |
| Last Name Of The Provider | CHOI |
| First Name Of The Provider | NOAH |
| View All |
Similar Doctors
|
|
Dr. Seth T. Stalcup, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Srinath C. Sampath, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard Sacknoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reginald E. Greene, MD
This Doctor is OpenDoctor Recommended.
|
|
|
G B. Harris |
|
|
Dr. Trevor J. Royce, MD |
|
|
Dr. Miranda B. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steve E. Braunstein, MD |
|
|
Dr. Jennifer Bellon, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frank Rybicki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Raymond H. Mak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Larissa J. Lee, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Anshu K. Jain, MD
This Doctor is OpenDoctor Recommended.
|